Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)

Name: Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)
License: Public Domain

Hospices Civils de Lyon

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

carcinoma

carcinoma, neuroendocrine

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 245493
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.